Iodine I 131 Monoclonal Antibody 3F8
N/A
Report date: 2026/01/26 17:58:58
Base Information
Drug NameIodine I 131 Monoclonal Antibody 3F8
Drug Alias Name
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesMemorial Sloan Kettering Cancer Center
Inactive CompaniesN/A
Active Indications +[10]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A